Matching placebo tablets
Sponsors
Reckitt Benckiser Healthcare (UK) Limited, Vyne Therapeutics Inc., GlaxoSmithKline, MedinCell S.A, NewAmsterdam Pharma
Conditions
AnaemiaCOVID-19DyspepsiaGastroesophageal Reflux DiseasePreclinical Alzheimer's DiseasePruritusPsoriasisRefractory Chronic Cough
Phase 2
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
CompletedNCT03282591
Start: 2017-10-03End: 2018-09-06Updated: 2021-05-20
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis
CompletedNCT03343639
Start: 2017-11-01End: 2018-11-12Updated: 2021-05-20
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
CompletedNCT03841331
Start: 2019-01-22End: 2020-01-21Updated: 2021-05-20
A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention
CompletedNCT05305560
Start: 2022-03-25End: 2022-10-13Updated: 2024-12-31
Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
Not yet recruitingNCT07794670
Start: 2026-09-01End: 2029-05-01Target: 400Updated: 2026-08-31
Phase 3
Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study
CompletedNCT01869491
Start: 2013-06-05End: 2014-05-31Updated: 2025-05-08
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
CompletedNCT03400033
Start: 2018-09-05End: 2020-06-19Updated: 2021-07-12